J&J Invests Over $1 Billion to Boost Vision Care Manufacturing in Florida
New Brunswick-based Johnson & Johnson recently announced an investment of more than $1 billion in Jacksonville, Florida to strengthen its Vision operations by scaling its U.S. manufacturing, packaging and distribution capabilities.
The investment includes construction of a new state-of-the-art distribution facility by 2028, alongside advanced manufacturing and packaging technologies to meet growing demand for Johnson & Johnson’s Acuvue brand contact lenses. The company currently manufactures more than 1.7 billion Acuvue contact lenses for U.S. patients.
“This investment reinforces our long-standing conviction that advanced manufacturing in the United States is essential to delivering innovative, high-quality healthcare solutions to patients at home and around the world,” Johnson & Johnson Chair and CEO Joaquin Duato said June 15.
Since establishing its Jacksonville presence in 1981, Johnson & Johnson has built a strong foundation for economic growth in the region. The latest $1 billion investment supports 3,500 Jacksonville employees and strengthens Johnson & Johnson’s $6 billion annual economic impact in Florida, the company said.
The Jacksonville facility is part of Johnson & Johnson’s previously announced $55 billion U.S. investment in manufacturing, research and development, and technology through early 2029. Other new manufacturing facilities include a $2 billion biologics plant in North Carolina, and a $1 billion next-generation cell therapy manufacturing facility in Pennsylvania.
“I am thrilled to see this major $1 billion investment in our state, funding new state-of-the-art facilities and supporting jobs in the Jacksonville area,” said U.S. Senator Ashley Moody (R-FL). “Companies are moving to Florida in droves, and massive investment such as this highlights Florida as the nation’s top state to grow your family and your business.”
